| Symbol | IMPZY |
|---|---|
| Name | IMPLANET SA |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | 33650 France Technopole Bordeaux Montesquieu Allee Francois Magendie |
| Telephone | +33557995555 |
| Fax | — |
| — | |
| Website | http://www.implanet.com/us/ |
| Incorporation | FR |
| Incorporated On | 2007 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Ernst & Young LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Euronext Paris |
| CIK | 0001661433 |
| Description | Implanet is a medical technology company based in France. The Company is engaged in the manufacturing, marketing and commercial development of implants and medical devices used in orthopedic surgery. The Companys products range covers knee surgery with a full range of total knee prosthesis and sport medicine implants. The Companys flagship product, the JAZZ technology platform, provides immobilization and fusion of spinal segments in the reduction of large deformities as well as the treatment of aging population. JAZZ is an adjunct to fusion implant of cervical, thoracic and lumbar spine. Additional info from OTC: |
No news found.